About Teletype
Join
S
Sheetal
@sheetal
June 29, 2020

Artificial Intelligence for Drug Discovery Market Forecast by 2020-2027

As per the research held by Acumen Research and Consulting, “the global Artificial Intelligence for Drug Discovery market anticipated to exceed US$ 8,149 Mn by 2027, along with the projected CAGR of 42% from 2020 to 2027”.

The global Artificial Intelligence for Drug Discovery market research report encompasses qualitative and quantitative data derived from the analysis by experts and research analysts in the respective industry verticals from valid sources with the help of primary and secondary research tools.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1621

The major market factors which are driving, hindering, challenging, or providing opportunities are specifically covered to better understand the market position, Recent market trends and governmental regulation & standards are additionally incorporated.

The research report has majorly profiled market information, DROs, segmentation, regional instance, and competitive landscape. The aforementioned entities further encompass prominent sections according to the need of the respective market. Moreover, regional segmentation includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and their respective major countries. The dipper information is profiled in terms of regions for getting recent and expected trends and opportunities in the regional market.

Furthermore, in terms of prominent players, the research report comprises a number of major players that are operating in the global competitive environment and offering advance and value-added products to the consumers. A detailed analysis is executed on these players in terms of the business snapshot, product offerings, financial overview, strategic development, player positioning, and R&D investment. This information is essential for the competitors and those who are planning to enter the market.

In a nutshell, the research report is a completely designed solution for those who are seeking information and available opportunities to take decisions of expansion in the desired market. As well as, the research report is also a value-added solution of the research students to get more specific information associated with the market.

Market participants

The players profiled in the report include Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics, Cloud Pharmaceuticals, Inc., BenevolentAI, twoXAR, and Exscientia.

Market segmentation

Market by Drug Type:

  • Small Molecule
  • Large Molecule

Market by Technology:

  • Deep Learning
  • Machine Learning

Market by Application:

  • Metabolic Disease
  • Cardiovascular Diseases
  • Oncology
  • Neurodegenerative Diseases
  • Others

Market by End use:

  • Pharmaceutical & Biotechnological Companies
  • Academic & Research Institutes
  • Others

Market by Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest if Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Meddle East & Africa

Table of content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Artificial Intelligence for Drug Discovery
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Artificial Intelligence for Drug Discovery Market By Drug Type
1.2.2.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Drug Type (2015-2026)
1.2.2.2. Global Artificial Intelligence for Drug Discovery Market Revenue Share By Drug Type in 2018
1.2.2.3. Small Molecule
1.2.2.4. Large Molecule
1.2.3. Artificial Intelligence for Drug Discovery Market By Technology
1.2.3.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Deep Learning
1.2.3.3. Machine Learning
1.2.4. Artificial Intelligence for Drug Discovery Market By Application
1.2.4.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Metabolic Disease
1.2.4.3. Cardiovascular Diseases
1.2.4.4. Oncology
1.2.4.5. Neurodegenerative Diseases
1.2.4.6. Others
1.2.5. Artificial Intelligence for Drug Discovery Market By End use
1.2.5.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.5.2. Pharmaceutical & Biotechnological Companies
1.2.5.3. Academic & Research Institutes
1.2.5.4. Others
1.2.6. Artificial Intelligence for Drug Discovery Market By Geography
1.2.6.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.3. Europe Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.4. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.5. Latin America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.6. Middle East and Africa (MEA)Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018

CHAPTER 4. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY DRUG TYPE
4.1. Global Artificial Intelligence for Drug Discovery Revenue By Drug Type
4.2. Small Molecule
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Large Molecule
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY TECHNOLOGY
5.1. Global Artificial Intelligence for Drug Discovery Revenue By Technology
5.2. Deep Learning
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Machine Learning
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY APPLICATION
6.1. Global Artificial Intelligence for Drug Discovery Revenue By Application
6.2. Metabolic Disease
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Cardiovascular Diseases
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Oncology
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. Neurodegenerative Diseases
6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.6. Others
6.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET By END USE
7.1. Global Artificial Intelligence for Drug Discovery Revenue By End Use
7.2. Pharmaceutical & Biotechnological Companies
7.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.3. Academic & Research Institutes
7.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.4. Others
7.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 8. NORTH AMERICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
8.1. North America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. North America Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Artificial Intelligence for Drug Discovery Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.3.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 9. EUROPE ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
9.1. Europe Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Europe Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.3.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.6.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.7.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
10.1. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.3.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.6.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.6.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.7.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.7.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
10.8.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.8.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.8.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 11. LATIN AMERICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
11.1. Latin America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Latin America Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.3.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.4.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.5.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
12.1. Middle East & Africa Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Middle East & Africa Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.3.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.4.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Drug Type, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
12.5.4. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Atomwise, Inc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Insilico Medicine
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. BIOAGE
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Numerate
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. NuMedii, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Envisagenics
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Cloud Pharmaceuticals, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. BenevolentAI
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. twoXAR
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Exscientia
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

REQUEST CUSTOMIZATION

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1621

Contact us:

Sheetal k

Email: [email protected]

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Acumen Research and Consulting (ARC)
June 29, 2020, 13:38
0 reactions
0 views